In a recently published market research study, Persistence Market Research presents a detailed opportunity analysis of the global anticancer drugs market, revealing key factors likely to have a significant impact on revenue growth of the anticancer drugs market in the next few years. Over the years, there has been an increasing emphasis on R&D in drug development and therapies for the...

In a recently published market research study, Persistence Market Research presents a detailed opportunity analysis of the global anticancer drugs market, revealing key factors likely to have a significant impact on revenue growth of the anticancer drugs market in the next few years. Over the years, there has been an increasing emphasis on R&D in drug development and therapies for the...

According to our new market research study titled "Drug Modeling Software Market – Global Analysis and Forecast – by Product Type, and Application" the global drug modeling software biopharmaceutical market is expected to reach US$ 11,299.85 million by 2027 from US$ 6,205.22 million in 2019; it is estimated to grow at a CAGR of 8.1% from 2020 to 2027. The report highlights the...

Generic Oncology Drugs Market Revenue at around US$ 23 Bn in 2020, which is predicted to rise to US$ 41.5 Bn by the end of 2031.The generic oncology drugs market is predicted to rise at a CAGR of around 6% over the decade. Rising incidence of cancer cases, increasing geriatric population, rising healthcare expenditure, and government initiatives to increase cancer treatment scope are some of...

Sales revenue from generic oncology drugs in 2020 was US$ 23 Bn, which is expected to surge to US$ 41.5 Bn by the end of 2031. Analysts at Persistence Market Research have also predicted the market to rise at a healthy CAGR of 6% over the next ten years. Instances of cancer cases have risen exponentially across the globe. From diagnosis to treatment, all aspects of the disease are...

Global Immuno-oncology Drugs Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 12.4% during the forecast period.Global Immuno-oncology Drugs Market Overview: Immuno-oncology is the artificial stimulation of the immune system to treat cancer, improving the immune system's ability to fight the disease. This needs to be personalized because anticancer immune responses...

The immuno-oncology therapy has shown excellent results in various clinical trials and in patients being treated with immune-oncology therapy. Immuno-oncology therapies can leverage patients’ immune system and re-program the same to attack cancer cells, providing a safe and effective alternative. There has been an increasing demand for immuno-oncology therapy as several...

In terms of revenue, global oncology drugs market was valued at US$ 119 billion in 2020. The introduction and approval of anti-PD-1 agents’ nivolumab and pembrolizumab for NSCLC has bought a new era for the cancer industry. The global Oncology Drugs market research is an intelligence report announced by Absolute Markets Insights. The erudite market study provides insightful data...

In terms of revenue, global oncology drugs market was valued at US$ 119 billion in 2020. The introduction and approval of anti-PD-1 agents’ nivolumab and pembrolizumab for NSCLC has bought a new era for the cancer industry. The global Oncology Drugs market research is an intelligence report announced by Absolute Markets Insights. The erudite market study provides insightful data...

The global Oncology Drugs market research is an intelligence report announced by Absolute Markets Insights. The erudite market study provides insightful data for readers to help them in making informed business decisions. Primary and secondary research methodologies have also been used to discover the correct and applicable data of Oncology Drugs market. Effective business strategies...